Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-07

FDA Approved: MYXREDLIN — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved a supplemental application for MYXREDLIN (insulin human) from Baxter Healthcare Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYXREDLIN (INSULIN HUMAN)

Snippet

SUPPL AP for MYXREDLIN (INSULIN HUMAN)